Skip to main content
FinSpry Logo
FinSpry
BEAM logo
BEAM
(NASDAQ)
Beam Therapeutics Inc.
$28.33-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Beam Therapeutics (BEAM) Stock Price & Financial Analysis

Beam Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.23 - $29.35
52-Week High$38.26
52-Week Low$15.60
Open$29.25
Volume1.24M
Average Volume (3M)1.91M
Market Cap3.07B
Shares Outstanding103.26M
Price to Sales (P/S)17.06
Price to Book (P/B)2.40
EV/EBITDA-35.92
Revenue (TTM)164.01M
Net Income (TTM)-65.04M
Free Cash Flow (TTM)-383.84M
EPS (TTM)$-0.63
Profit Margin-39.66%
Operating Margin-226.58%
Return on Equity (ROE)-5.59%
Debt to Equity0.22
50-Day MA$29.95
200-Day MA$28.09
52-Week Change58.48%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Beam Therapeutics

What is the current stock price for BEAM?

As of the latest trading session, BEAM stock trades at $28.33. The 52-week range is $15.60–$38.26, with a day range of $28.23–$29.35.

What is the P/E ratio for BEAM?

The P/E ratio (Price-to-Earnings) for BEAM is shown in the Key Statistics section. This valuation metric helps compare Beam Therapeutics Inc. to industry peers.

Does BEAM pay dividends?

Beam Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BEAM?

Based on 4 analysts, the consensus for BEAM is Buy.

What is the market cap of BEAM?

Beam Therapeutics's market capitalization is $2.93B, classifying it as a mid-cap company. Beam Therapeutics operates in the Healthcare sector within the Biotechnology industry.